Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL. Foss, F. M., Querfeld, C., Kim, Y. H., Pinter-Brown, L. C., William, B. M., Porcu, P., Pacheco, T., Haverkos, B., DeSimone, J., Guitart, J., Halwani, A., Eradat, H., Huen, A., Seto, A. G., Pestano, L. A., Gordon, G., Escolar, D., Rubin, P., Marshall, W. S., Williams, J. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.2511

View details for Web of Science ID 000442916001291